ReCLIP (Reversible Cross-Link Immuno-Precipitation): An Efficient Method for Interrogation of Labile Protein Complexes by Smith, Andrew L. et al.
ReCLIP (Reversible Cross-Link Immuno-Precipitation): An
Efficient Method for Interrogation of Labile Protein
Complexes
Andrew L. Smith
1, David B. Friedman
2, Huapeng Yu
1, Robert H. Carnahan
1, Albert B. Reynolds
1*
1Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee, United States of America, 2Mass Spectrometry Research Center, Department of Biochemistry,
Vanderbilt University, Nashville, Tennessee, United States of America
Abstract
The difficulty of maintaining intact protein complexes while minimizing non-specific background remains a significant
limitation in proteomic studies. Labile interactions, such as the interaction between p120-catenin and the E-cadherin
complex, are particularly challenging. Using the cadherin complex as a model-system, we have developed a procedure for
efficient recovery of otherwise labile protein-protein interactions. We have named the procedure ‘‘ReCLIP’’ (Reversible Cross-
Link Immuno-Precipitation) to reflect the primary elements of the method. Using cell-permeable, thiol-cleavable
crosslinkers, normally labile interactions (i.e. p120 and E-cadherin) are stabilized in situ prior to isolation. After
immunoprecipitation, crosslinked binding partners are selectively released and all other components of the procedure (i.e.
beads, antibody, and p120 itself) are discarded. The end result is extremely efficient recovery with exceptionally low
background. ReCLIP therefore appears to provide an excellent alternative to currently available affinity-purification
approaches, particularly for studies of labile complexes.
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Introduction
Identifying functionally relevant protein-protein interactions
remains a significant problem in discovery-based research. Affinity
purification coupled with Mass Spectrometry (MS) analysis is a
rapid, sensitive, and unbiased method for identifying novel
protein-protein interactions. While ongoing technical advances
have dramatically improved the sensitivity and efficiency of mass
spectrometry instruments and methods, most experiments are
limited by the quality of the sample itself. Current methods
represent a compromise where recovery is sacrificed for specificity
or vise versa. Conventional co-immunoprecipitation by itself is
invariably accompanied by unacceptable background. A common
solution is to add a second affinity purification step. This Tandem-
Affinity-Purification (TAP-tag) approach, however, minimizes
background at the expense of transient and/or weak interactions
that are lost because of the additional processing [1], [2].
Here, we have used p120-catenin (hereafter p120) and the E-
cadherin complex as a model to develop an approach that
captures labile interactions without sacrificing specificity. p120-
catenin was originally identified as a prominent Src substrate, and
later as a core component of classical cadherin complexes [3], [4].
Cadherins constitute a family of trans-membrane homophilic cell-
cell adhesion receptors that interact in trans to link adjacent cells
[5]. Adhesiveness is regulated, in part, by the catenins (i.e., a-
catenin, b-catenin, c-catenin/plakoglobin and p120-catenin)
which bind to the cytoplasmic tail to form the cadherin complex
[6]. b-catenin and c-catenin directly bind to cadherins in a
mutually exclusive manner, and physically and/or functionally
link the complex to a-catenin and the actin cytoskeleton [7], [8].
Whereas b- and c-catenins bind cadherins with high affinity
under a variety of conditions, the p120 interaction is relatively
labile. In RIPA buffer, for example, p120 is almost undetectable in
cadherin immunoprecipitates, whereas the other catenins are
efficiently recovered. Gentler detergents (i.e. NP-40) improve
recovery, but are nonetheless relatively inefficient [4]. Digitonin
can effectively preserve p120 binding in some cell types, but
appears to act selectively on soluble (as opposed to cytoskeleton
tethered) complexes [4], [9] and previous attempts using TAP
methods have been unsuccessful due to extremely low recovery of
p120 complexes (unpublished observations).
Chemical crosslinkers have been employed to stabilize protein-
protein interactions for structural studies [10], or to demonstrate
interaction between already suspected binding partners [11]. For
example, it has been used successfully to capture transient
dimerization of the Epidermal Growth Factor Receptor in response
to ligand [12]. In particular, the cell-permeable, lysine-reactive
crosslinker Dithiobis[succinimidyl propionate] (DSP, also called
Lamont’s Reagent) has been successfully used to facilitate co-
immunoprecipitation of weakly interacting binding partners [13].
Recently, DSP-crosslinking has been combined with affinity-
purification and mass spectrometry to identify novel binding
partners [14], [15], suggesting that in-cell crosslinking can be used
tocharacterizeweakandtransientcomplexesbymassspectrometry.
PLoS ONE | www.plosone.org 1 January 2011 | Volume 6 | Issue 1 | e16206Here, using p120 and the cadherin complex as a model system,
we describe an efficient approach that employs cell-permeable,
thiol-cleavable crosslinkers to stabilize normally labile interactions
(i.e. the p120 - E-cadherin interaction) in vivo prior to cell lysis and
affinity purification. In our model, p120 was directly immunopre-
cipitated under stringent conditions and binding partners were
selectively eluted from the p120 ‘‘bait’’ by chemical cleavage of the
crosslinker. Unlike other approaches, this elution scheme removes
the target protein along with the beads and antibody from the final
sample, resulting in very low background. Western blot and MS
analyses revealed that all core components of the cadherin
complex were efficiently recovered along with several novel
candidates for direct or indirect p120 binding partners. This
approach, which we have termed ReCLIP (Reversible Cross-Link
Immuno-Precipitation) is simple and produced remarkably clean
preparations of p120 binding partners for proteomic analyses.
These results suggest that ReCLIP provides high sensitivity
without sacrificing specificity, and therefore provides a robust
alternative to other affinity-purification methods.
Results
Determination of optimal crosslinker concentrations
We initially identified candidate crosslinkers and evaluated
conditions for use. Two specific crosslinkers, Dithiobis[succinimi-
dyl propionate] (DSP) and Dithio-bismaleimidoethane (DTME),
were chosen based on their distinct chemical properties. DSP
reacts with primary amines and has a spacer-arm of 12 A ˚
(Figure 1e), forming crosslinks between lysine residues of
interacting proteins. DSP has been commonly used in a variety
protein-interaction studies [16], [10] due in part to the high
abundance of lysine residues in proteins. DTME reacts with
sulfhydryl groups and has a spacer arm of 13.3 A ˚ (Figure 1f),
forming crosslinks between cysteine residues of interacting
proteins. DTME would be expected to produce fewer crosslinks,
however it may capture interactions that DSP cannot. While not
commonly used, DTME has been successfully applied to protein-
protein interactions studies [17]. Importantly, both compounds
are cell-permeable, allowing for in-cell crosslinking of endogenous
complexes prior to cell-lysis. Additionally, both compounds are
thiol-cleavablez, allowing for ‘‘reversal’’ of the crosslinks via
chemical cleavage by a reducing agent (i.e. DTT).
Optimal crosslinker conditions were determined using A431
epidermoid carcinoma cells, a human epithelial cell line that has
been used for a number of cell-cell adhesion studies [18], [19].
A431 cells were washed with PBS and exposed for 30 minutes to
increasing concentrations of DSP or DTME (Figure 1) in PBS,
pH 7.4. Cells were then lysed at 4uC in RIPA and the lysates
treated for 15 min with DTT (reducing, panels b and d) or not
(nonreducing, panels a and c), as indicated. Samples were then
Figure 1. Titration of intracellular cross-linking of p120 and E-cadherin. Western blot analysis of E-cadherin (top panels) and p120 (bottom
panels) in whole cell lysates of A431 cells treated with the indicated concentrations of DSP (a, b) or DTME (c, d) between 0.01 mM and 1.0 mM.
Samples were prepared under non-reducing (a, c) and reducing conditions (b, d) as indicated. Arrowheads indicate monomeric E-cadherin and p120,
large cross-linked species are indicated with arrows, smaller crosslinked E-cadherin species are indicated with a diamond (X), and a possible cysteine-
induced E-cadherin dimer is indicated with an asterisk (*). The chemical structures of DSP (e) and DTME (f) are shown, images were constructed with
the DrawIt application in KnowItAll Informatics System v. 4.1 (Bio-Rad).
doi:10.1371/journal.pone.0016206.g001
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cadherin (top panels) or p120 (bottom panels).
Figure 1a shows a dose-dependent reduction in monomeric E-
cadherin (top panel, arrowhead) and the simultaneous appearance
of crosslinked complexes across the top of the gel that are too large
to resolve (arrow). Note that the monomeric E-cadherin (and
p120, lower panel) is decreased at 0.5 mM DSP and almost absent
at 1.0 mM, indicating that the vast majority of E-cadherin and
p120 is crosslinked into high molecular complexes at these
concentrations. Figure 1b shows that monomeric protein is
efficiently recovered by addition of DTT. Note that at 0.5 mM
DSP, virtually all of the monomeric E-cadherin and over half of
the monomeric p120 are recovered (compare lanes 6 in a and b,
upper and lower panels respectively), and that the high molecular
weight bands are no longer present. It is not entirely clear why the
recovery of p120 in whole cell lysates is less efficient than that for
E-cadherin. The difference, however, is not generally observed in
immunoprecipitates, suggesting that the phenomenon may reflect
competition for reducing agent among the large number of
crosslinked proteins present in the whole cell lysate.
Crosslinking with DTME was less efficient, as evidenced by the
relatively high levels of monomeric E-cadherin remaining at the
1.0 mM dose (panel c, compare lanes 1 and 6). This is consistent
with the lower abundance of cysteine residues relative to lysine.
Nonetheless, the appearance of progressively larger E-cadherin-
containing complexes with increasing DTME indicates the
presence of crosslinked species. The faster migrating band
(Fig. 1c, diamond) probably represents a partial complex. The
exact content is not known, but p120 is clearly absent. Further
crosslinking generates p120-containing higher order complexes,
which are too large to resolve by SDS-PAGE (arrow). In these
non-reduced samples, an additional E-cadherin band is present
even in the absence of cross-linker (asterisk). The precise identity of
this E-cadherin complex is unclear, but it may represent cadherin
dimers caused by the addition of cysteine to quench the DTME
crosslinking reaction, as dimerization is induced, in part, by
cysteine mediated disulfide bonds within the extracellular domain
[20], [21]. Interestingly, for reasons not entirely clear, DTME
appears to crosslink p120 more efficiently than E-cadherin, as
evidenced by significant loss of monomeric p120 (panel c, compare
lanes 1 through 6).
Based on these data, we chose 0.5 mM DSP and 0.5 mM
DTME as optimal concentrations for subsequent experiments. In
the case of DSP, 1.0 mM was more effective than 0.5 mM, but we
chose the lesser of the two to limit nonspecific capture. For
DTME, there was no apparent difference between 1.0 and
0.5 mM so the lesser amount was used.
Efficacy, efficiency, and specificity of crosslinking with
DSP and DTME
Next, we used the E-cadherin – p120 interaction as a model to
assess the efficacy of DSP and DTME under the above conditions.
The amount of E-cadherin co-immunoprecipitating with p120 was
determined after in-cell crosslinking with DSP or DTME
(Figure 2a). Cell lysis in a digitonin-containing buffer (without
crosslinking) was used as a reference (Figure 2a, lane 1), because it
Figure 2. In-cell cross-linking preserves the interaction of p120 and E-cadherin and is specific for interacting proteins. (a) Western
blot analysis of p120, E-cadherin, FAK, and p42/44 MAPK in p120 immunoprecipitates and lysates from A431 cells lysed in 1% digitonin or RIPA buffer
following treatment with DMSO vehicle or 0.5 mM cross-linker as indicated. (b) Cadherin-negative A431-D cells, and A431-D cells stably expressing
wild type (WT E-cad) or p120-uncoupled (764 E-cad) E-cadherin were prepared and analyzed as in A. (c) Western blot analysis of p120, E-cadherin, b-
catenin, and a-catenin in p120, control IgG immunoprecipitates, and lysates from A431 cells treated as in panel a.
doi:10.1371/journal.pone.0016206.g002
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cadherin interaction [9]. In contrast, the remaining samples were
treated with DSP, DTME, or vehicle alone (DMSO), as above,
and lysed in RIPA buffer. p120 was then immunoprecipitated
from all samples, eluted in reducing LSB, and analyzed by SDS-
PAGE and Western blotting.
Figure 2a shows that E-cadherin recovery from p120
immunoprecipitates after DSP crosslinking was as good, if not
better, than that obtained from the digitonin lysate (compare
lanes 1 and 3). DTME was less efficient (lane 4), whereas no E-
cadherin was recovered in the absence of crosslinker (i.e. DMSO,
lane 2). Thus, E-cadherin was not recovered in RIPA alone, but
crosslinking with DSP preserved the interaction. Moreover,
irrelevant cytoplasmic (i.e. MAP Kinase) and membrane-
associated (i.e. Focal Adhesion Kinase) proteins were absent
from the p120 immunoprecipitates but clearly present in whole
cell lysates. Thus, DSP and DTME crosslinking appears to be
quite specific under these conditions.
To further assess specificity, we asked whether E-cadherin and
p120 could be crosslinked under conditions where physical
interaction is selectively uncoupled (Figure 2b). We previously
described a minimal E-cadherin mutant (E-cad 764AAA) that is
physically uncoupled from p120 but nonetheless forms cell-cell
junctions and interacts normally with b-catenin [22]. In Figure 2b,
we introduced WT (lanes 5–8) or mutant (lanes 9–12) E-cadherin
into the A431D cell line, a cadherin-negative A431 variant. The
absence of E-cad 764AAA in p120 immunoprecipitations (lanes 9–
12, top panel) shows clearly that this mutant is not crosslinked to
p120, implying that direct physical interaction is indeed essential.
In contrast, WT E-cadherin is efficiently crosslinked (lanes 5–8,
top panel).
To further test the efficacy of crosslinking, we extended the
analysis to a- and b-catenins, which form a tertiary (indirect)
complex with p120 via E-cadherin (Figure 2c). Interestingly, the
entire complex is efficiently crosslinked by DSP (lane 4). a-catenin,
in particular, was easily recovered relative to the DTME or
digitonin methods. The middle panels (lanes 5–8) show that
negative-control immunoprecipitation with a p120 monoclonal
antibody that does not recognize human p120 (control IgG, mAb
8D11) under conditions identical to the first panel (lanes 1–4) does
not bring down members of the cadherin complex.
Reversible Cross-Linking Immuno-Precipitation (ReCLIP)
for Mass Spectrometry
Figure 3 illustrates the procedure we have developed for rapid
and clean isolation of binding partners for MS analysis. The
schematic (panel 3a) shows immunoprecipitation of a crosslinked
p120 complex followed by selective elution of the individual
components. Binding partners are efficiently recovered by
breaking the crosslinks with reducing agent, essentially reversing
the procedure. With the antibody covalently bound to the bead
(see bead preparation under Materials and Methods), DTT
releases crosslinked binding partners only. The most abundant
protein ‘contaminants’, mAb 15D2 and mAb-bound p120 itself
(the bait), are discarded along with the beads, resulting in a highly
purified mixture of eluted binding partners. Panel b illustrates the
efficiency of the immunoprecipitation, as evidenced by depletion
of p120 from the supernatant (panel b, compare lanes 1 and 2).
Panel c shows that the coimmunoprecipitated E-cadherin is
efficiently recovered by DTT elution (panel c, top panel, compare
lanes 1 and 2) while p120 is essentially absent, having been
discarded with the beads (panel c, bottom panel, lane 2).
Figure 3. Elution of binding partners from p120. (a) A schematic of the elution strategy. Following immunoprecipitation and washing of cross-
linked complexes on p120 mAb beads, binding partners are released by incubation with DTT in RIPA buffer, cleaving the cross-links and releasing
interacting proteins from p120. (b) A representative western blot demonstrating depletion of p120 from A431 cell lysates following
immunoprecipitation with p120 mAb beads of control IgG beads. Tubulin is shown as a loading control. (c) Elution of known binding partners,
but not p120, from p120 mAb beads. Whole cell lysate is shown as a control, and 10% of the DTT eluate was analyzed for E-cadherin, b-catenin, a-
catenin, and p120 by Western blot.
doi:10.1371/journal.pone.0016206.g003
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does not deplete p120 from the lysate (panel b, lane 3) or and E-
cadherin and associated catenins are not detected in the DTT
eluate (panel c, lane 3).
Efficacy of ReCLIP
To test the efficacy of ReCLIP, p120 and control elutions from
A431 cells crosslinked with DSP were subjected to shotgun
analysis by single-dimension liquid chromatography tandem mass
spectrometry (LC-MS/MS). Core p120 binding partners were
easily identified, as evidenced by high spectral counts for E-
cadherin and the catenins (Table 1). Note, however, that spectral
counts are only partly indicative of protein abundance. For
example, E-cadherin is consistently under-represented relative to
its size, which is similar to the catenins. Importantly, cadherin
proteins are not detected control pull downs (i.e. zero peptides), as
shown in Table 1. Nonspecific background (ie, proteins detected in
both experimental and control samples) was remarkably low,
consisting primarily of common artifacts such as chaperones,
metabolic proteins, and highly abundant cytoskeletal proteins, as
illustrated in Table S1.
Effects of simultaneous DSP and DTME crosslinking
zNext,weaskedwhetheruseofDSPandDTMEtogetherismore
efficient than either one alone. Figure 4a shows the number of
distinct peptides (per protein) of cadherin complex proteins detected
using individual or combined crosslinkers. Complete peptide
identification data (including peptide sequences and cross-correla-
tion scores) is provided in Table S2. For E-cadherin and a-catenin,
combining DSP and DTME was clearly more efficient than
individual usage, whereas no little or no improvement was observed
for b-catenin and Plakoglobin. The same result is illustrated by
Western blotting (Figure 4b) using E-cadherin as the readout. In the
experiment shown, the DSP + DTME combination was highly
effective (compare lanes 7 and 8), whereas each compound by itself
was less efficient (compare lane 1 and 2, and lane 4 and 5).
The efficacy of ReCLIP under three crosslinking conditions was
further evaluated by SDS-PAGE and silver staining (figure 4c).
The data indicate an excellent signal to noise ratio across all three
conditions, with very few bands detectable in control IgG lanes
(lanes 2, 4, and 6). For each condition, some of the bands were
unique, as expected. Notably, combining DSP and DTME
captured most of the individual bands observed with either
crosslinker alone while background remained remarkably low
(compare lanes 5 and 6). These data indicate that regardless of the
crosslinker used, ReCLIP provides robust recovery with very low
background.
In addition to the core components of the cadherin complex, we
identified at least 15 unique candidate p120 binding partners in
MS analysis, and grouped them according to the condition that
resulted in the highest number of peptide hits (Figure 4d–f). For
example, Figure 4d contains the candidates for which DSP and
DTME together yielded more hits than DSP (4e) or DTME (4f)
alone. The cutoff for inclusion was a minimum of two hits against
a background of zero, although the majority exceeded these
criteria. Complete peptide identification data for these candidates
is provided in Table S2. As expected, the highest number of
peptide hits for most of the candidates was obtained when DSP
and DTME were combined (panel d). However, for five of the
candidates, the highest number of hits was obtained using DSP
alone (Figure 4e), whereas DTME was optimal for only one
protein (Figure 4f). Interestingly, five of the candidates were
captured only when DSP and DTME were used together. On the
other hand, combining DSP and DTME prevented capture of
three candidates (MSH2, GOLGA4, and AIFM1). In general, the
use of both DSP and DTME together was most effective in that
the majority of candidates (12/15) were detected and only three
were missed. With DSP or DTME alone, just over half of the
candidates (8/15) were missed. Overall, these data suggest that the
most effective approach is to combine DSP and DTME, but this
approach may not be ideal for all proteins. Thus, it is
recommended that investigators test each crosslinker individually
and in combination in order to determine the appropriate
ReCLIP condition for a given target protein.
Discussion
Here, we have used reversible in-cell crosslinking to develop an
extremely efficient method (ReCLIP) for studying protein
complexes by mass spectrometry. The component techniques by
themselves are not necessarily novel, but they are uniquely
combined and optimized to generate a powerful method for
studying labile complexes. The single immunoprecipitation
approach minimizes sample loss, a common problem in TAP
methods. Furthermore, covalent crosslinking preserves relevant
interactions despite stringent lysis and washing conditions that
reduce background. Thus ReCLIP appears to be particularly
powerful for studying labile protein interactions that in principle
could be lost using TAP approaches.
Among the several optimized parameters of the ReCLIP
method, two in particular turn out to be critical. First, in-cell
crosslinking covalently stabilizes endogenous interactions (as they
occur in vivo). Thus, weak or transient interactions are captured in
situ and retained, regardless of subsequent lysis and washing
conditions, until the very end of the procedure when the product is
eluted. Second, the elution method itself is both gentle and highly
selective. A major difference between ReCLIP and other methods
is that only putative binding partners are eluted when the
crosslinks are cleaved (see Figure 3a). Thus, beads, antibody, and
Table 1. Recovery and identification of core p120 binding partners using ReCLIP.
Protein
UniProt
Accession
Average spectral count
in p120 IP
Standard
Error
Average spectral count
in control IP
E-cadherin IPI00000513.1 9 2.11 0
a-catenin IPI00215948.4 38 9.17 0
b-catenin IPI00017292.1 24 6.07 0
Plakoglobin IPI00554711.2 12 5.08 0
Average spectral totals for E-cadherin, a-catenin, b-catenin, and Plakoglobin from 3 independent ReCLIP experiments from A431 cells treated with DSP. No peptides for
these proteins were identified in the corresponding control samples.
doi:10.1371/journal.pone.0016206.t001
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this case, p120) are completely absent from final sample. The
removal of bait and immunoprecipitating antibodies from the
sample is important because these are by far the most abundant
protein contaminants present in most methods.
A potential consideration when using ReCLIP in conjunction
with MS is that some of the recovered peptides are covalently
bound by a cleaved crosslinker. After cleavage by reducing agent,
half of each crosslinker remains attached to a target residue in the
crosslinked protein. In addition, bound crosslinker may alter
proteolytic cleavage patterns, as has been demonstrated for other
lysine modifications [23]. In addition The cleaved crosslinker
alters peptide mass and can prevent recognition by standard MS
algorithms [24]. Both events (mass-shift and reduced cleavage) can
reduce the number of peptides generated and/or detected. Such
complications are not likely to affect the data significantly because
crosslinked peptides represent only a small fraction of the total
number generated following digestion of the sample with trypsin.
The effect is further limited by using the minimal effective
concentration of the crosslinker, as determined by preliminary
titration experiments. It is also possible to identify modified
peptides by re-analyzing the spectra using a subset database that
allows for the extra mass (105.16 Da per Lysine for DSP and
159.21 Da per Cysteine for DTME) produced by the cleaved
crosslinker [25].
One potential drawback to ReCLIP is that very low molecular
weight proteins might be missed because there are fewer available
sites for crosslinking, and fewer tryptic peptides to detect. For
example, if a protein is crosslinked and contains only two tryptic
peptides, one will be missed due to the crosslink modification.
Such proteins would be overlooked because the score (one peptide
against zero background) is below the cutoff for positive
identification. Thus, small proteins (e.g. small GTPases such as
RhoA) may be overlooked, because few unmodified peptides are
Figure 4. Cross-linkers can be combined to enhance complex recovery. (a) Average number of distinct peptides identified in 2 LC-MS/MS
runs for E-cadherin, a-catenin, b-catenin, and plakoglobin from A431 cells treated with DSP, DTME, or both compounds simultaneously (DSP + DTME).
Error bars represent standard error of the mean. Background levels were similar across all conditions. (b) Western blot analysis of E-cadherin levelsi n
lysates (Lysate), p120 eluates (p120), and control IgG eluates (Control) from A431 cells treated with the indicated cross-linkers. (c) Silver stain analysis
of total protein recovery from p120 and control IgG eluates from each condition (DSP, DTME, or DSP + DTME). (d–f) Average distinct peptide recovery
of 15 additional putative p120 binding partners under each cross-linking condition. Proteins were grouped based on whether more peptides were
detected using the combination of DSP and DTME (d), DSP alone (e) or DTME alone (f).
doi:10.1371/journal.pone.0016206.g004
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coverage when assessing proteins with relatively low peptide scores
(e.g. two peptides against zero background).
ReCLIP has been optimized to study endogenous complexes
using a monoclonal antibody. By design, this allows physiologically
relevant complexes to be recovered with a relatively high degree of
specificity. However, ReCLIP can still be used in conjunction
epitope-tags (e.g., Flag, Myc, HA epitope tags) in cases where
specific antibodies are not available. Protein overexpression,
however, may increase nonspecific interactions. For example, we
have noticed that components of the proteasome are selectively
identified under such conditions. Presumably, the cell is targeting
the excess protein for degradation and we are then crosslinking it
to components of the proteasome. It is possible that we missed
certain previously identified p120 binding partners (e.g., Kinesin
Heavy Chain [26], [27]). for this reason, as the interaction
between p120 and Kinesin Heavy Chain is more efficiently
detected under conditions of p120 overexpression. Alternatively,
the interaction may be different or absent in A431 cells.
Surprisingly, Kaiso was not identified as a p120 binding partner
by ReCLIP. However, Kaiso is a relatively low abundance
transcriptional repressor found primarily in the nucleus in cultured
cells [28]. Thus, it is possible that spatial separation, low Kaiso
expression, low interaction stoichiometry, or any combination
thereof ultimately limits the sensitivity of ReCLIP. Of note, p120
and Kaiso can be detected by conventional co-immunoprecipita-
tion in gentle detergent buffers [28], suggesting that low
abundance of Kaiso is not by itself the limiting factor. Instead,
cell lysis without prior crosslinking may actually facilitate such
interactions by permitting the mixing of proteins from otherwise
spatially separate pools (e.g. nuclear Kaiso and cytoplasmic p120).
With ReCLIP, protein complexes are crosslinked in situ and then
lysed in RIPA, a stringent buffer designed expressly to be
compatible with antibody-antigen interactions while preventing
nonspecific and/or weak interactions. Thus, some events that
occur post-lysis (e.g. the p120-Kaiso interaction) will undoubtedly
be prevented by the ReCLIP lysis and washing conditions. On the
other hand, this feature of ReCLIP may allow one to selectively
capture physiological complexes under a defined condition and
time interval, potentially identifying interactions that occur
transiently in response to a stimulus.
In addition to the cadherin complex, we identified several
candidate p120 binding partners (Figure 4c–e and Table S2)
including p160 Rho Kinase (ROCK1). ROCK1 is a prominent
effector of RhoA that regulates the acto-myosin machinery and
other signaling pathways [29]. This novel interaction, which will
be described in a separate report (Smith et al. in preparation), is
consistent with other known roles of p120. For example, p120
regulates the activity of RhoA [30] and can associate with p190
RhoGAP at the adherens junction [31]. ROCK1 has not been
linked to p120 by other methods (e.g. conventional immunopre-
cipitation and TAP-Tag), consistent with the apparent increased
sensitivity of ReCLIP. Interestingly, no Rho-family GTPases were
detected using ReCLIP, including RhoA which has been reported
to directly interact with p120 [32], [33]. A potential explanation
for this result is the inherent bias of mass-spectrometry against
small proteins. Nonetheless, the recovery of ROCK1 along with its
substrate Villin-2/Ezrin suggests that a functional Rho complex
associates with p120.
Another candidate binding partner, cd98 (also known as 4F2
Heavy Chain), appears to reflect capture of a tertiary interaction.
In general, tertiary (as apposed to direct) interactions are
considerably more difficult to capture by conventional methods,
but in principle could be significantly stabilized by limited
crosslinking. cd98 is an integral membrane protein that forms a
heterodimer with the LAT-2 amino-acid transporter (also known
as 4F2 Light Chain) [34]. cd98 also regulates b1-integrin
clustering [35], [36], [37] and heterotypic cell-cell interactions
[38]. Interestingly, a previous study suggested the recruitment of
cd98 to cadherin-based cell-cell junctions [34]. Consistent with
this report, we find that cd98 co-localizes precisely with E-
cadherin and p120 in A431 cells (see Figure S1a). However, in E-
cadherin reconstitution experiments (using the cadherin-negative
A431 derivative, A431D) cd98 is also recruited to both wild type
and p120 uncoupled E-cadherin complexes, indicating that the
direct interaction is not with p120 itself, but instead to some other
member of the E-cadherin complex (see Figure S1b). As with
ROCK1, we have not detected cd98 by other methods.
Importantly, the indirect association of p120 with cd98 provides
additional evidence that ReCLIP can routinely capture tertiary
interactions that would otherwise be lost, making it attractive for
interactome mapping studies.
In summary, we have developed ReCLIP (Reversible Cross-
Link Immuno-Precipitation), an approach designed expressly to
retain weak interactions without sacrificing specificity and/or
sensitivity. The procedure is relatively simple and yet generates
excellent signal-to-noise ratios in MS analyses. Although we have
focused on the cadherin complex as a model system, the method
should be broadly applicable. Overall, ReCLIP offers a potentially
powerful alternative to previously described affinity-purification
approaches and appears to be particularly suitable for interrogat-
ing labile protein complexes.
Materials and Methods
Cell Lines and Cell Culture
A431 and A431D epidermoid cervical carcinoma cell lines were
obtained from Dr. Margaret Wheelock (University of Nebraska
Medical Center). A431D cells expressing wild type (WT) or
764AAA E-cadherin [22] were generated using the LZRS-MS-neo
retroviral vector as described previously [39], [40]. All cells were
cultured in DMEM (Gibco/Invitrogen) supplemented with
10% FBS (Hyclone) and 1% penicillin-streptomycin (Gibco/
Invitrogen).
In-cell chemical cross-linking
In-cell cross-linking was performed using Dithiobis[succinimidyl
propionate] (DSP) and Dithio-bismaleimidoethane (DTME)
(Pierce/Thermo Scientific). For each experiment, cross-linkers
were freshly prepared as a 20 mM solution in Dimethyl Sulfoxide
(DMSO) and diluted to the indicated final working concentrations
in Phosphate-buffered saline, pH 7.4 (PBS, Fisher Scientific). Cells
were washed twice with PBS at room temperature to remove all
traces of media and incubated with the cross-linker solution for 30
minutes at room temperature. After removal of the cross-linker
solution, cells were incubated at room temperature for 10 minutes
with quenching solution (20 mM Tris-Cl pH 7.4, 5 mM L-
Cysteine). Quenching solution was then removed and cell lysates
were prepared as described below.
Antibodies and Bead Preparation
The generation of monoclonal and polyclonal antibodies for
p120 (pp120, 15D2, 8D11, F1aSH) has been described [41]. Of
note, mAb 15D2 was used for all p120 immunoprecipitations,
while mAb 8D11 is used as a control IgG because it does not
recognize human p120. Other antibodies used include E-cadherin
monoclonal antibody (BD Transduction), a-catenin rabbit poly-
clonal antibody (C-2081, Sigma), b-catenin rabbit polyclonal
Reversible Cross-Link Immuno-Precipitation
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antibody (Cell Signaling), and Focal Adhesion Kinase (FAK)
rabbit polyclonal antibody (C-20, Santa Cruz). Anti-cd98
monoclonal antibody 4F2 was a kind gift from Dr. Roy Zent
[42], [43]. Secondary antibodies for western blot analysis include
anti-mouse AlexaFluor 680 (Molecular Probes) and anti-rabbit
IRdye 800 (Rockland Immunochemicals).
To prepare magnetic beads for immunoprecipitation, Protein G
Dynabeads (Dynal/Invitrogen) were washed with Citrate Phos-
phate buffer pH 5.0 (25 mM citric acid, 50 mM dibasic sodium
phosphate) and incubated with either 15D2 or 8D11 monoclonal
antibodies for 2 hours at room temperature with end-over-end
rotation. Bead-antibody complexes were washed with citrate
phosphate buffer, followed by two washes with 0.2 M Trietha-
nolamine (TEA) pH 8.2. Antibodies were covalently bound to
Protein G beads by incubation 20 mM Dimethyl Pimelimidate
(Sigma) in TEA for 30 minutes at room temperature with end-
over-end rotation, followed by incubation for 15 minutes with
50 mM Tris to quench the crosslinking reaction. Subsequently,
beads were washed three times with PBS-Tween. After washing
with 0.1 M Glycine, pH 2.5 to remove non-covalently bound
antibodies, beads where washed again with PBS-Tween and stored
at 4uC.
Conventional Immunoprecipitation and Western Blot
Analysis
Lysis, immunoprecipitation, and western blot methods have
been described previously [40]. Briefly, cells were lysed in
Radioimmunoprecipitation Assay (RIPA) buffer (50 mM Tris
pH 7.4, 150 mM NaCl, 1% NP-40, 0.5% deoxycholic acid, 0.1%
SDS) or Digitonin buffer (20 mM Tris pH 7.5, 150 mM NaCl,
1% Digitonin) supplemented with protease and phosphatase
inhibitors (1 mM PMSF, 5 mg/mL Leupeptin, 2 mg/mL Aproti-
nin, 1 mM EDTA, 50 mM NaF, and 1 mM NaVO4). Lysates
were cleared by centrifugation and total protein concentrations
were determined by BCA assay (Pierce/Thermo Scientific). For
immunoprecipitation, the specified antibody was added to the
clarified lysate for 2 hours at 4uC with end-over-end rotation,
followed by incubation with Protein G sepharose (GE Healthcare)
for an additional hour at 4uC. Beads were washed with lysis buffer,
resuspended in 26Laemmli Sample Buffer (LSB), and boiled for 5
minutes. Lysates were prepared in LSB or non-reducing sample
buffer (50 mM Tris pH 6.8, 4% Glycerol, 1% SDS, 0.004%
Bromophenol Blue) as indicated. Cross-linked lysates were
incubated with 50 mM DTT for 15 minutes prior to boiling to
ensure cleavage of disulfide bonds within the cross-linkers.
Immunoprecipitations and whole cell lysates were separated by
SDS-PAGE and transferred to nitrocellulose membranes (What-
man) for western blotting. Non-specific binding to membranes was
blocked with 3% nonfat milk in TBS (10 mM Tris pH 7.4,
150 mM NaCl), and membranes were incubated with primary
antibody in milk overnight at 4uC. Membranes were incubated
with secondary antibody in Odyssey blocking buffer (Li-Cor) for
1 hour at room temperature. Antibodies were detected using the
Odyssey infrared imaging system (Li-Cor).
Reversible Cross-Link Immunoprecipitation Procedure
Four 15 cm dishes of 90% confluent A431 cells (1610
8 cells)
were used for each experiment. Cells were washed twice with
freshly-prepared PBS pH 7.4 to remove all traces of media.
Following removal of PBS, 10 mL of a 0.5 mM crosslinker
solution in PBS (as described above) was added to the each plate.
Cells were incubated with crosslinkers for 30 minutes at room
temperature, with occasional agitation. Crosslinker solution was
then removed, and 10 mL quenching solution was added to each
plate for an additional 10 minutes. Following quenching, plates
were placed on an ice bath and washed once more with chilled
PBS, and lysed with freshly-prepared RIPA buffer plus protease
and phosphatase inhibitors (1 mL RIPA buffer per dish). Lysates
were homogenized using a 23-gauge needle and cleared by
centrifugation. Equal volumes of clarified lysate were incubated
with either 15D2 (p120) or 8D11 (control) bound Protein G
Dynabeads for 3 hours at 4uC with end-over-end rotation. The
beads were then washed 5 times with 1 mL RIPA buffer
supplemented with protease and phosphatase inhibitors. p120
binding partners were eluted by incubating the beads with RIPA
buffer supplemented with 50 mM DTT in for 30 minutes at 37uC
with end-over-end rotation.
For mass spectrometry analysis, eluates were boiled in freshly
prepared LSB, separated by SDS-PAGE on a Nu-PAGE 4–12%
Bis-Tris gels (Novex/Invitrogen) and stained with ‘‘Blue Silver’’
colloidal coomassie stain [44]. The entire lane was excised and
processed for shotgun analysis using single-dimension liquid-
chromatography tandem-mass spectrometry (LC-MS/MS) by the
Vanderbilt University Medical Center Proteomics Core. For silver
stain analysis, 10% of the eluate was separated by SDS-PAGE and
protein was visualized using Silver Stain Plus (Bio-Rad), according
to the manufacturer’s protocols. Following staining, gels were
imaged using the FluorChem-8900 Gel Documentation System
(Alpha Innotech).
Mass Spectrometry and Protein Identification
Proteins were resolved by SDS-PAGE, and protein bands of
interest were excised and cut into 1 mm cubes and equilibrated in
50 mM NH4HCO3. Proteins were then reduced within the gel
pieces with DTT (3 mM in 100 mM NH4HCO3,3 7 uC for
15 min) followed by alkylation with iodoacetamide (6 mM in
50 mM NH4HCO3 for 15 min). The gel pieces were then
dehydrated with acetonitrile and rehydrated with 15 mL
12.5 mM NH4HCO3 containing 0.01 mg/mL trypsin (Trypsin
Gold, Promega), and trypsin digestion was carried out for .2ha t
37uC. Peptides were extracted with 60% acetonitrile, 0.1% formic
acid, dried by vacuum centrifugation and reconstituted in 15 mL
0.1% formic acid. 5 mL of peptide hydrosylate were analyzed by
C18 reverse-phase LC-MS/MS using a Thermo LTQ ion trap
mass spectrometer equipped with a Thermo MicroAS autosam-
pler and Thermo Surveyor HPLC pump, nanospray source, and
Xcalibur 2.0 instrument control using standard triple-play
methods. Tandem MS data were analyzed with the Sequest
algorithm to search a human subset of the UniRef100 database
(Jan 23 2007, 223514 entries) using Xcorr cutoffs of §1.8 for
[M+2H]
2+/2 ions and §2.5 for [M+3H]
3+/3 ions. In addition,
the database contained a concatenated reverse decoy database to
estimate false-discovery rates, which were at 5% or below.
Immunofluorescence Microscopy. Immunofluorescence
staining and microscopy procedures are described in Material S1.
Supporting Information
Figure S1 Immunofluorescent analysis of p120 and cd98 in
A431 and A431D cells.
(TIF)
Material S1 Supplementary methods (Immunofluorescence
Microscopy), figure legend for figure S1, and legends for Tables
S1 and S2.
(DOC)
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negative control ReCLIP samples are shown.
(XLS)
Table S2 Complete peptide identification data (peptide se-
quence, cross correlation (X-corr) score, ion hits, and charge (z))
for proteins described in Figure 4.
(XLS)
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